High density lipoprotein natural history, complications and prognosis

Jump to navigation Jump to search

High Density Lipoprotein Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Physiology

Pathophysiology

Causes

Low HDL
High HDL

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

HDL Laboratory Test

Treatment

Medical Therapy

Prevention

Future or Investigational Therapies

Clinical Trials

Landmark Trials

List of All Trials

Case Studies

Case #1

High density lipoprotein natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of High density lipoprotein natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on High density lipoprotein natural history, complications and prognosis

CDC on High density lipoprotein natural history, complications and prognosis

High density lipoprotein natural history, complications and prognosis in the news

Blogs on High density lipoprotein natural history, complications and prognosis

Directions to Hospitals Treating High density lipoprotein

Risk calculators and risk factors for High density lipoprotein natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]

Overview

The plasma levels of HDL are inversely proportional to the development of coronary artery disease (CAD) making HDL a positive cardiac risk factor.[1] Low serum HDL-cholesterol can be an isolated abnormality or can be associated with hypercholesterolemia. Patients with premature coronary artery disease, defined as CAD in men less than 55 to 60 years of age and women less than 65 years of age, have a primary reduction in HDL-cholesterol. Studies have shown that low HDL risk is independent of the risk attributed to elevated LDL-cholesterol (low density lipoprotein) in the serum.

Low HDL and Cardiovascular Risk

The Framingham Heart Study has shown that the risk of myocardial infarction increases by about 25% for every 5 mg/dL decrement in serum HDL-cholesterol below median values for both men and women.[2]

References

  1. Rajagopal G, Suresh V, Sachan A (2012). "High-density lipoprotein cholesterol: How High". Indian J Endocrinol Metab. 16 (Suppl 2): S236–8. doi:10.4103/2230-8210.104048. PMC 3603035. PMID 23565387. Unknown parameter |month= ignored (help)
  2. Wilson PW, Abbott RD, Castelli WP (1988). "High density lipoprotein cholesterol and mortality. The Framingham Heart Study". Arteriosclerosis. 8 (6): 737–41. PMID 3196218.

Template:WikiDoc Sources